action of glp 1 agonist GLP-1 and Anesthesia: Considerations and Cautions for CRNAs PDB-101: Molecule of the Month:

The GLP1-RAs vs sodium-glucose cotransporter-2 (SGLT-2) inhibitors cohort included new users of GLP-1 RAs (n=83,464) or SGLT-2 inhibitors (n=78,366), and the GLP1-RAs vs dipeptidyl peptidase-4 (DPP-4) inhibitors cohort included new users of GLP-1 RAs (n=108,322) or DPP-4 inhibitors (n=55,411)

Delve into the perspectives of employers and health plans on obesity, GLP-1 coverage rates, and concerns about off-label use.

Here's what researchers found.

Discover current prescription statistics, usage trends, patient demographics, and access patterns for GLP-1 receptor agonists in the US healthcare system.

The weight loss medications can be part of a long-term treatment strategy for adults, according to new World Health Organization guidelines.